{"id":5158,"date":"2021-06-09T13:29:25","date_gmt":"2021-06-09T17:29:25","guid":{"rendered":"https:\/\/diaztradelaw.com\/?post_type=product&#038;p=5158"},"modified":"2023-06-21T14:03:37","modified_gmt":"2023-06-21T18:03:37","slug":"fda-is-it-a-cosmetic-a-drug-or-both-mitigating-fda-enforcement-actions","status":"publish","type":"product","link":"https:\/\/diaztradelaw.com\/product\/fda-is-it-a-cosmetic-a-drug-or-both-mitigating-fda-enforcement-actions\/","title":{"rendered":"FDA &#8211; Is it a Cosmetic, a Drug, or Both? Mitigating FDA Enforcement Actions"},"content":{"rendered":"<p>This one-hour webinar provides an overview of FDA regulatory enforcement actions. You will learn about FDA regulations and laws pertaining to over-the-counter (OTC) drugs and cosmetics marketed in the United States. The presentation will discuss real scenarios, including labeling dos and don&#8217;ts. The objective of the webinar is to teach manufacturers, importers, and the like, how to navigate FDA&#8217;s regulatory framework, provide TOP compliance tips to avoid FDA enforcement actions, and strategies when you are faced with an enforcement action.<\/p>\n<p>In This Webinar You Will Learn:<br \/>\n&#8211; How FDA Regulates OTC Drug and Cosmetic Products (and How to Differentiate Your Product)<br \/>\n&#8211; Labeling Dos and Don&#8217;ts (Including a Discussion on Intended use)<br \/>\n&#8211; Top Tips for Compliance<br \/>\n&#8211; Types of FDA Enforcement Actions<br \/>\n&#8211; Best Practices for Responding to Enforcement Actions (Including Real Life Examples)<\/p>\n<p>Presenters:<br \/>\n&#8211; Jennifer Diaz<br \/>\n&#8211; Denise Calle<\/p>\n<p>Who Should Attend:<br \/>\n&#8211; Importers<br \/>\n&#8211; Customs Brokers<br \/>\n&#8211; Regulatory Affairs Professionals<br \/>\n&#8211; In-house Legal Counsel<br \/>\n&#8211; Product Development Managers<br \/>\n&#8211; Others Interested in FDA<\/p>\n<p>Eligible for 1 CCS\/MCS\/CES\/MES NEI Credit<br \/>\n&#8211; Input your NCBFAA NEI ID number at the time of registration to receive credit<\/p>\n","protected":false},"excerpt":{"rendered":"<p>This one-hour webinar provides an overview of FDA regulatory enforcement actions. You will learn about FDA regulations and laws pertaining to over-the-counter (OTC) drugs and cosmetics marketed in the United States. The presentation will discuss real scenarios, including labeling dos and don&#8217;ts. The objective of the webinar is to teach manufacturers, importers, and the like, how to navigate FDA&#8217;s regulatory framework, provide TOP compliance tips to avoid FDA enforcement actions, and strategies when you are faced with an enforcement action. In This Webinar You Will Learn: &#8211; How FDA Regulates OTC Drug and Cosmetic Products (and How to Differentiate Your Product) &#8211; Labeling Dos and Don&#8217;ts (Including a Discussion on Intended use) &#8211; Top Tips for Compliance &#8211; Types of FDA Enforcement Actions &#8211; Best Practices for Responding to Enforcement Actions (Including Real Life Examples) Presenters: &#8211; Jennifer Diaz &#8211; Denise Calle Who Should Attend: &#8211; Importers &#8211; Customs Brokers &#8211; Regulatory Affairs Professionals &#8211; In-house Legal Counsel &#8211; Product Development Managers &#8211; Others Interested in FDA Eligible for 1 CCS\/MCS\/CES\/MES NEI Credit &#8211; Input your NCBFAA NEI ID number at the time of registration to receive credit<\/p>\n","protected":false},"featured_media":6517,"comment_status":"open","ping_status":"closed","template":"","meta":[],"product_brand":[],"product_cat":[900],"product_tag":[],"class_list":{"0":"post-5158","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-fda-101","8":"first","9":"instock","10":"virtual","11":"sold-individually","12":"purchasable","13":"product-type-simple"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.1.1 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>FDA - Is it a Cosmetic, a Drug, or Both? Mitigating FDA Enforcement Actions - Customs &amp; International Trade Law Firm<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/diaztradelaw.com\/product\/fda-is-it-a-cosmetic-a-drug-or-both-mitigating-fda-enforcement-actions\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"FDA - Is it a Cosmetic, a Drug, or Both? Mitigating FDA Enforcement Actions - Customs &amp; International Trade Law Firm\" \/>\n<meta property=\"og:description\" content=\"This one-hour webinar provides an overview of FDA regulatory enforcement actions. You will learn about FDA regulations and laws pertaining to over-the-counter (OTC) drugs and cosmetics marketed in the United States. The presentation will discuss real scenarios, including labeling dos and don&#8217;ts. The objective of the webinar is to teach manufacturers, importers, and the like, how to navigate FDA&#8217;s regulatory framework, provide TOP compliance tips to avoid FDA enforcement actions, and strategies when you are faced with an enforcement action. In This Webinar You Will Learn: &#8211; How FDA Regulates OTC Drug and Cosmetic Products (and How to Differentiate Your Product) &#8211; Labeling Dos and Don&#8217;ts (Including a Discussion on Intended use) &#8211; Top Tips for Compliance &#8211; Types of FDA Enforcement Actions &#8211; Best Practices for Responding to Enforcement Actions (Including Real Life Examples) Presenters: &#8211; Jennifer Diaz &#8211; Denise Calle Who Should Attend: &#8211; Importers &#8211; Customs Brokers &#8211; Regulatory Affairs Professionals &#8211; In-house Legal Counsel &#8211; Product Development Managers &#8211; Others Interested in FDA Eligible for 1 CCS\/MCS\/CES\/MES NEI Credit &#8211; Input your NCBFAA NEI ID number at the time of registration to receive credit\" \/>\n<meta property=\"og:url\" content=\"https:\/\/diaztradelaw.com\/product\/fda-is-it-a-cosmetic-a-drug-or-both-mitigating-fda-enforcement-actions\/\" \/>\n<meta property=\"og:site_name\" content=\"Customs &amp; International Trade Law Firm\" \/>\n<meta property=\"article:publisher\" content=\"http:\/\/facebook.com\/diaztradelaw\" \/>\n<meta property=\"article:modified_time\" content=\"2023-06-21T18:03:37+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/diaztradelaw.com\/wp-content\/uploads\/2022\/09\/17a-.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2000\" \/>\n\t<meta property=\"og:image:height\" content=\"1333\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@diaztradelaw\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/diaztradelaw.com\/product\/fda-is-it-a-cosmetic-a-drug-or-both-mitigating-fda-enforcement-actions\/\",\"url\":\"https:\/\/diaztradelaw.com\/product\/fda-is-it-a-cosmetic-a-drug-or-both-mitigating-fda-enforcement-actions\/\",\"name\":\"FDA - Is it a Cosmetic, a Drug, or Both? Mitigating FDA Enforcement Actions - Customs &amp; International Trade Law Firm\",\"isPartOf\":{\"@id\":\"https:\/\/diaztradelaw.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/diaztradelaw.com\/product\/fda-is-it-a-cosmetic-a-drug-or-both-mitigating-fda-enforcement-actions\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/diaztradelaw.com\/product\/fda-is-it-a-cosmetic-a-drug-or-both-mitigating-fda-enforcement-actions\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/i0.wp.com\/diaztradelaw.com\/wp-content\/uploads\/2022\/09\/17a-.jpg?fit=2000%2C1333&ssl=1\",\"datePublished\":\"2021-06-09T17:29:25+00:00\",\"dateModified\":\"2023-06-21T18:03:37+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/diaztradelaw.com\/product\/fda-is-it-a-cosmetic-a-drug-or-both-mitigating-fda-enforcement-actions\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/diaztradelaw.com\/product\/fda-is-it-a-cosmetic-a-drug-or-both-mitigating-fda-enforcement-actions\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/diaztradelaw.com\/product\/fda-is-it-a-cosmetic-a-drug-or-both-mitigating-fda-enforcement-actions\/#primaryimage\",\"url\":\"https:\/\/i0.wp.com\/diaztradelaw.com\/wp-content\/uploads\/2022\/09\/17a-.jpg?fit=2000%2C1333&ssl=1\",\"contentUrl\":\"https:\/\/i0.wp.com\/diaztradelaw.com\/wp-content\/uploads\/2022\/09\/17a-.jpg?fit=2000%2C1333&ssl=1\",\"width\":2000,\"height\":1333,\"caption\":\"cosmetic or drug\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/diaztradelaw.com\/product\/fda-is-it-a-cosmetic-a-drug-or-both-mitigating-fda-enforcement-actions\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/diaztradelaw.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Shop\",\"item\":\"https:\/\/diaztradelaw.com\/shop\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"FDA &#8211; Is it a Cosmetic, a Drug, or Both? Mitigating FDA Enforcement Actions\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/diaztradelaw.com\/#website\",\"url\":\"https:\/\/diaztradelaw.com\/\",\"name\":\"Customs &amp; International Trade Law Firm\",\"description\":\"Jennifer Diaz\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/diaztradelaw.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"FDA - Is it a Cosmetic, a Drug, or Both? Mitigating FDA Enforcement Actions - Customs &amp; International Trade Law Firm","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/diaztradelaw.com\/product\/fda-is-it-a-cosmetic-a-drug-or-both-mitigating-fda-enforcement-actions\/","og_locale":"en_US","og_type":"article","og_title":"FDA - Is it a Cosmetic, a Drug, or Both? Mitigating FDA Enforcement Actions - Customs &amp; International Trade Law Firm","og_description":"This one-hour webinar provides an overview of FDA regulatory enforcement actions. You will learn about FDA regulations and laws pertaining to over-the-counter (OTC) drugs and cosmetics marketed in the United States. The presentation will discuss real scenarios, including labeling dos and don&#8217;ts. The objective of the webinar is to teach manufacturers, importers, and the like, how to navigate FDA&#8217;s regulatory framework, provide TOP compliance tips to avoid FDA enforcement actions, and strategies when you are faced with an enforcement action. In This Webinar You Will Learn: &#8211; How FDA Regulates OTC Drug and Cosmetic Products (and How to Differentiate Your Product) &#8211; Labeling Dos and Don&#8217;ts (Including a Discussion on Intended use) &#8211; Top Tips for Compliance &#8211; Types of FDA Enforcement Actions &#8211; Best Practices for Responding to Enforcement Actions (Including Real Life Examples) Presenters: &#8211; Jennifer Diaz &#8211; Denise Calle Who Should Attend: &#8211; Importers &#8211; Customs Brokers &#8211; Regulatory Affairs Professionals &#8211; In-house Legal Counsel &#8211; Product Development Managers &#8211; Others Interested in FDA Eligible for 1 CCS\/MCS\/CES\/MES NEI Credit &#8211; Input your NCBFAA NEI ID number at the time of registration to receive credit","og_url":"https:\/\/diaztradelaw.com\/product\/fda-is-it-a-cosmetic-a-drug-or-both-mitigating-fda-enforcement-actions\/","og_site_name":"Customs &amp; International Trade Law Firm","article_publisher":"http:\/\/facebook.com\/diaztradelaw","article_modified_time":"2023-06-21T18:03:37+00:00","og_image":[{"width":2000,"height":1333,"url":"https:\/\/diaztradelaw.com\/wp-content\/uploads\/2022\/09\/17a-.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_site":"@diaztradelaw","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/diaztradelaw.com\/product\/fda-is-it-a-cosmetic-a-drug-or-both-mitigating-fda-enforcement-actions\/","url":"https:\/\/diaztradelaw.com\/product\/fda-is-it-a-cosmetic-a-drug-or-both-mitigating-fda-enforcement-actions\/","name":"FDA - Is it a Cosmetic, a Drug, or Both? Mitigating FDA Enforcement Actions - Customs &amp; International Trade Law Firm","isPartOf":{"@id":"https:\/\/diaztradelaw.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/diaztradelaw.com\/product\/fda-is-it-a-cosmetic-a-drug-or-both-mitigating-fda-enforcement-actions\/#primaryimage"},"image":{"@id":"https:\/\/diaztradelaw.com\/product\/fda-is-it-a-cosmetic-a-drug-or-both-mitigating-fda-enforcement-actions\/#primaryimage"},"thumbnailUrl":"https:\/\/i0.wp.com\/diaztradelaw.com\/wp-content\/uploads\/2022\/09\/17a-.jpg?fit=2000%2C1333&ssl=1","datePublished":"2021-06-09T17:29:25+00:00","dateModified":"2023-06-21T18:03:37+00:00","breadcrumb":{"@id":"https:\/\/diaztradelaw.com\/product\/fda-is-it-a-cosmetic-a-drug-or-both-mitigating-fda-enforcement-actions\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/diaztradelaw.com\/product\/fda-is-it-a-cosmetic-a-drug-or-both-mitigating-fda-enforcement-actions\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/diaztradelaw.com\/product\/fda-is-it-a-cosmetic-a-drug-or-both-mitigating-fda-enforcement-actions\/#primaryimage","url":"https:\/\/i0.wp.com\/diaztradelaw.com\/wp-content\/uploads\/2022\/09\/17a-.jpg?fit=2000%2C1333&ssl=1","contentUrl":"https:\/\/i0.wp.com\/diaztradelaw.com\/wp-content\/uploads\/2022\/09\/17a-.jpg?fit=2000%2C1333&ssl=1","width":2000,"height":1333,"caption":"cosmetic or drug"},{"@type":"BreadcrumbList","@id":"https:\/\/diaztradelaw.com\/product\/fda-is-it-a-cosmetic-a-drug-or-both-mitigating-fda-enforcement-actions\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/diaztradelaw.com\/"},{"@type":"ListItem","position":2,"name":"Shop","item":"https:\/\/diaztradelaw.com\/shop\/"},{"@type":"ListItem","position":3,"name":"FDA &#8211; Is it a Cosmetic, a Drug, or Both? Mitigating FDA Enforcement Actions"}]},{"@type":"WebSite","@id":"https:\/\/diaztradelaw.com\/#website","url":"https:\/\/diaztradelaw.com\/","name":"Customs &amp; International Trade Law Firm","description":"Jennifer Diaz","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/diaztradelaw.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/diaztradelaw.com\/wp-json\/wp\/v2\/product\/5158","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/diaztradelaw.com\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/diaztradelaw.com\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/diaztradelaw.com\/wp-json\/wp\/v2\/comments?post=5158"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/diaztradelaw.com\/wp-json\/wp\/v2\/media\/6517"}],"wp:attachment":[{"href":"https:\/\/diaztradelaw.com\/wp-json\/wp\/v2\/media?parent=5158"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/diaztradelaw.com\/wp-json\/wp\/v2\/product_brand?post=5158"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/diaztradelaw.com\/wp-json\/wp\/v2\/product_cat?post=5158"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/diaztradelaw.com\/wp-json\/wp\/v2\/product_tag?post=5158"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}